Hepatitis E virus in patients with unexplained hepatitis in Finland

Journal of Clinical Virology

Volumn 45, Issue 2, 2009, Pages 109-113

  Kantala, Tuija ^a   Maunula, Leena ^a   von Bonsdorff, Carl Henrik ^a   Peltomaa, Jaakko ^a   Lappalainen, Maija ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Hepatitis E; Hepatitis E virus; HEV; Unexplained hepatitis

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA;

ACUTE HEPATITIS; ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINLAND; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT INFORMATION; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CLUSTER ANALYSIS; FEMALE; FINLAND; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 67349203560     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.03.006     Document Type: Article

References (45)

1. Tam A.W., Smith M.M., Guerra M.E., Huang C.C., Bradley D.W., Fry K.E., et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185 (1991) 120-131
2. Emerson S.U., Anderson D., Arankalle A., Meng X.J., Purdy M., Schlauder G.G., et al. Hepevirus. In: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball L.A. (Eds). Virus taxonomy: VIIIth report of the ICTV (2004), Elsevier/Academic Press, London 851-855
3. Purcell R.H., and Emerson S.U. Hepatitis E virus. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 4th edition vol. 2 (2001), Lippincott Williams & Wilkins, Philadelphia 3051-3061
4. Emerson S.U., and Purcell R.H. Hepatitis E virus. Rev Med Virol 13 (2003) 145-154
5. Mast E.E., and Krawczynski K. Hepatitis E: an overview. Annu Rev Med 47 (1996) 257-266
6. Worm H.C., van der Poel W.H., and Brandstatter G. Hepatitis E: an overview. Microbes Infect 4 (2002) 657-666
7. Panda S.K., Thakral D., and Rehman S. Hepatitis E virus. Rev Med Virol 17 (2007) 151-180
8. Lu L., Li C., and Hagedorn C.H. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 16 (2006) 5-36
9. Teo C.G. Hepatitis E indigenous to economically developed countries: to what extent a zoonosis?. Curr Opin Infect Dis 19 (2006) 460-466
10. Aggarwal R., and Krawczynski K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 15 (2000) 9-20
11. Schlauder G.G., and Mushahwar I.K. Genetic heterogeneity of hepatitis E virus. J Med Virol 65 (2001) 282-292
12. Zhai L., Dai X., and Meng J. Hepatitis E virus genotyping based on full-length genome and partial genomic regions. Virus Res 120 (2006) 57-69
13. Haqshenas G., Shivaprasad H.L., Woolcock P.R., Read D.H., and Meng X.J. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J Gen Virol 82 (2001) 2449-2462
14. Purcell R.H., and Emerson S.U. Hepatitis E: an emerging awareness of an old disease. J Hepatol 48 (2008) 494-503
15. Okamoto H., Takahashi M., and Nishizawa T. Features of hepatitis E virus infection in Japan. Intern Med 42 (2003) 1065-1071
16. Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res 127 (2007) 216-228
17. Waar K., Herremans M.M., Vennema H., Koopmans M.P., and Benne C.A. Hepatitis E is a cause of unexplained hepatitis in The Netherlands. J Clin Virol 33 (2005) 145-149
18. Herremans M., Vennema H., Bakker J., van der Veer B., Duizer E., Benne C.A., et al. Swine-like hepatitis E viruses are a cause of unexplained hepatitis in the Netherlands. J Viral Hepat 14 (2007) 140-146
19. Borgen K., Herremans T., Duizer E., Vennema H., Rutjes S., Bosman A., et al. Non-travel related hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004-2006. BMC Infect Dis 8 (2008) 61
20. Ijaz S., Arnold E., Banks M., Bendall R.P., Cramp M.E., Cunningham R., et al. Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 192 (2005) 1166-1172
21. Dalton H.R., Stableforth W., Hazeldine S., Thurairajah P., Ramnarace R., Warshow U., et al. Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A. Eur J Clin Microbiol Infect Dis 27 (2008) 579-585
22. Lewis H.C., Boisson S., Ijaz S., Hewitt K., Ngui S.L., Boxall E., et al. Hepatitis E in England and Wales. Emerg Infect Dis 14 (2008) 165-167
23. Mansuy J.M., Peron J.M., Abravanel F., Poirson H., Dubois M., Miedouge M., et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 74 (2004) 419-424
24. Peron J.M., Mansuy J.M., Poirson H., Bureau C., Dupuis E., Alric L., et al. Hepatitis E is an autochthonous disease in industrialized countries. Analysis of 23 patients in south-west France over a 13-month period and comparison with hepatitis A. Gastroenterol Clin Biol 30 (2006) 757-762
25. Buti M., Clemente-Casares P., Jardi R., Formiga-Cruz M., Schaper M., Valdes A., et al. Sporadic cases of acute autochthonous hepatitis E in Spain. J Hepatol 41 (2004) 126-131
26. Reuter G., Fodor D., Katai A., and Szucs G. Identification of a novel variant of human hepatitis E virus in Hungary. J Clin Virol 36 (2006) 100-102
27. Haagsman A., Reuter G., Duizer E., Nagy G., Herremans T., Koopmans M., et al. Seroepidemiology of hepatitis E virus in patients with non-A, non-B, non-C hepatitis in Hungary. J Med Virol 79 (2007) 927-930
28. Boutrouille A., Bakkali-Kassimi L., Cruciere C., and Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 45 (2007) 2009-2010
29. Mansuy J.M., Legrand-Abravanel F., Calot J.P., Peron J.M., Alric L., Agudo S., et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 80 (2008) 289-293
30. Mateos M.L., Camarero C., Lasa E., Teruel J.L., Mir N., and Baquero F. Hepatitis E virus: relevance in blood donors and risk groups. Vox Sang 76 (1999) 78-80
31. Sylvan S.P., Jacobson S.H., and Christenson B. Prevalence of antibodies to hepatitis E virus among hemodialysis patients in Sweden. J Med Virol 54 (1998) 38-43
32. Olsen B., Axelsson-Olsson D., Thelin A., and Weiland O. Unexpected high prevalence of IgG-antibodies to hepatitis E virus in Swedish pig farmers and controls. Scand J Infect Dis. 38 (2006) 55-58
33. Orrú G., Masia G., Orrú G., Romano L., Piras V., and Coppola R.C. Detection and quantitation of hepatitis E virus in human faeces by real-time quantitative PCR. J Virol Methods 118 (2004) 77-82
34. Clayson E.T., Myint K.S., Snitbhan R., Vaughn D.W., Innis B.L., Chan L., et al. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J Infect Dis 172 (1995) 927-933
35. Aggarwal R., Kini D., Sofat S., Naik S.R., and Krawczynski K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 356 (2000) 1081-1082
36. Favorov M.O., Fields H.A., Purdy M.A., Yashina T.L., Aleksandrov A.G., Alter M.J., et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 36 (1992) 246-250
37. Bendall R., Ellis V., Ijaz S., Thurairajah P., and Dalton H.R. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 80 (2008) 95-101
38. Mitsui T., Tsukamoto Y., Suzuki S., Yamazaki C., Masuko K., Tsuda F., et al. Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals. J Med Virol 76 (2005) 526-533
39. Worm H.C., Wurzer H., and Frosner G. Sporadic hepatitis E in Austria. N Engl J Med 339 (1998) 1554-1555
40. Herremans M., Bakker J., Duizer E., Vennema H., and Koopmans M.P. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 14 (2007) 562-568
41. Lin C.C., Wu J.C., Chang T.T., Chang W.Y., Yu M.L., Tam A.W., et al. Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol 38 (2000) 3915-3918
42. Zhang J.Z., Im S.W., Lau S.H., Chau T.N., Lai S.T., Ng S.P., et al. Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis. J Med Virol 66 (2002) 40-48
43. Daniel H.D., Warier A., Abraham P., and Sridharan G. Age-wise exposure rates to hepatitis E virus in a southern Indian patient population without liver disease. Am J Trop Med Hyg 71 (2004) 675-678
44. Mizuo H., Yazaki Y., Sugawara K., Tsuda F., Takahashi M., Nishizawa T., et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol 76 (2005) 341-349
45. Ohnishi S., Kang J.H., Maekubo H., Arakawa T., Karino Y., Toyota J., et al. Comparison of clinical features of acute hepatitis caused by hepatitis E virus (HEV) genotypes 3 and 4 in Sapporo, Japan. Hepatol Res 36 (2006) 301-307